HLA Allele-specific Expression: Methods, Disease Associations, and Relevance in Hematopoietic Stem Cell Transplantation

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Oct 17

PMID 36248878

Authors

Tiira Johansson

Jukka Partanen

Paivi Saavalainen

Affiliations

Soon will be listed here.

Abstract

Varying HLA allele-specific expression levels are associated with human diseases, such as graft versus host disease (GvHD) in hematopoietic stem cell transplantation (HSCT), cytotoxic T cell response and viral load in HIV infection, and the risk of Crohn's disease. Only recently, RNA-based next generation sequencing (NGS) methodologies with accompanying bioinformatics tools have emerged to quantify HLA allele-specific expression replacing the quantitative PCR (qPCR) -based methods. These novel NGS approaches enable the systematic analysis of the HLA allele-specific expression changes between individuals and between normal and disease phenotypes. Additionally, analyzing HLA allele-specific expression and allele-specific expression loss provide important information for predicting efficacies of novel immune cell therapies. Here, we review available RNA sequencing-based approaches and computational tools for NGS to quantify HLA allele-specific expression. Moreover, we explore recent studies reporting disease associations with differential HLA expression. Finally, we discuss the role of allele-specific expression in HSCT and how considering the expression quantification in recipient-donor matching could improve the outcome of HSCT.

Citing Articles

Variation within the non-coding genome influences genetic and epigenetic regulation of the human leukocyte antigen genes.

Arumugam T, Adimulam T, Gokul A, Ramsuran V Front Immunol. 2024; 15:1422834.

PMID: 39355248 PMC: 11442197. DOI: 10.3389/fimmu.2024.1422834.

Risk factors and survival outcomes in children with early cardiotoxicity after allogeneic hematopoietic stem cell transplantation.

Tong K, Meng Y, Zhang L, Lei X, Liu Q, Guan X Ann Hematol. 2024; 103(7):2485-2497.

PMID: 38709259 DOI: 10.1007/s00277-024-05787-9.

Narrative Review Explaining the Role of , , and Molecules in COVID-19 Disease in and around Africa.

Naidoo L, Arumugam T, Ramsuran V Infect Dis Rep. 2024; 16(2):380-406.

PMID: 38667755 PMC: 11049896. DOI: 10.3390/idr16020029.

Nucleotide alterations in the HLA-C class I gene can cause aberrant splicing and marked changes in RNA levels in a polymorphic context-dependent manner.

Mizutani A, Suzuki S, Shigenari A, Sato T, Tanaka M, Kulski J Front Immunol. 2024; 14:1332636.

PMID: 38327766 PMC: 10847315. DOI: 10.3389/fimmu.2023.1332636.

Comparison between qPCR and RNA-seq reveals challenges of quantifying HLA expression.

Aguiar V, Castelli E, Single R, Bashirova A, Ramsuran V, Kulkarni S Immunogenetics. 2023; 75(3):249-262.

PMID: 36707444 PMC: 9883133. DOI: 10.1007/s00251-023-01296-7.

References

Ramsuran V, Naranbhai V, Horowitz A, Qi Y, Martin M, Yuki Y . Elevated expression impairs HIV control through inhibition of NKG2A-expressing cells. Science. 2018; 359(6371):86-90. PMC: 5933048. DOI: 10.1126/science.aam8825. View

Dellgren C, Nehlin J, Barington T . Cell surface expression level variation between two common Human Leukocyte Antigen alleles, HLA-A2 and HLA-B8, is dependent on the structure of the C terminal part of the alpha 2 and the alpha 3 domains. PLoS One. 2015; 10(8):e0135385. PMC: 4530957. DOI: 10.1371/journal.pone.0135385. View

Hiraki A, Fujii N, Murakami T, Kiura K, Aoe K, Yamane H . High frequency of allele-specific down-regulation of HLA class I expression in lung cancer cell lines. Anticancer Res. 2004; 24(3a):1525-8. View

Bray N, Pimentel H, Melsted P, Pachter L . Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol. 2016; 34(5):525-7. DOI: 10.1038/nbt.3519. View

Weider T, Richardson S, Morgan N, Paulsen T, Dahl-Jorgensen K, Hammerstad S . HLA Class I Upregulation and Antiviral Immune Responses in Graves Disease. J Clin Endocrinol Metab. 2020; 106(4):e1763-e1774. PMC: 7993595. DOI: 10.1210/clinem/dgaa958. View

Lank S, Wiseman R, Dudley D, OConnor D . A novel single cDNA amplicon pyrosequencing method for high-throughput, cost-effective sequence-based HLA class I genotyping. Hum Immunol. 2010; 71(10):1011-7. PMC: 3191540. DOI: 10.1016/j.humimm.2010.07.012. View

Boegel S, Lower M, Bukur T, Sahin U, Castle J . A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines. Oncoimmunology. 2015; 3(8):e954893. PMC: 4355981. DOI: 10.4161/21624011.2014.954893. View

Rene C, Lozano C, Eliaou J . Expression of classical HLA class I molecules: regulation and clinical impacts: Julia Bodmer Award Review 2015. HLA. 2016; 87(5):338-49. DOI: 10.1111/tan.12787. View

Patro R, Duggal G, Love M, Irizarry R, Kingsford C . Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017; 14(4):417-419. PMC: 5600148. DOI: 10.1038/nmeth.4197. View

10.

Shiina T, Hosomichi K, Inoko H, Kulski J . The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet. 2009; 54(1):15-39. DOI: 10.1038/jhg.2008.5. View

11.

Kivioja T, Vaharautio A, Karlsson K, Bonke M, Enge M, Linnarsson S . Counting absolute numbers of molecules using unique molecular identifiers. Nat Methods. 2011; 9(1):72-4. DOI: 10.1038/nmeth.1778. View

12.

Le Morvan C, Cogne M, Drouet M . HLA-A and HLA-B transcription decrease with ageing in peripheral blood leucocytes. Clin Exp Immunol. 2001; 125(2):245-50. PMC: 1906127. DOI: 10.1046/j.1365-2249.2001.01610.x. View

13.

Michelakos T, Kontos F, Kurokawa T, Cai L, Sadagopan A, Krijgsman D . Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancer. J Immunother Cancer. 2022; 10(3). PMC: 8919449. DOI: 10.1136/jitc-2021-004115. View

14.

McGranahan N, Rosenthal R, Hiley C, Rowan A, Watkins T, Wilson G . Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution. Cell. 2017; 171(6):1259-1271.e11. PMC: 5720478. DOI: 10.1016/j.cell.2017.10.001. View

15.

Voorter C, Gerritsen K, Groeneweg M, Wieten L, Tilanus M . The role of gene polymorphism in HLA class I splicing. Int J Immunogenet. 2016; 43(2):65-78. DOI: 10.1111/iji.12256. View

16.

Sabbatino F, Villani V, Yearley J, Deshpande V, Cai L, Konstantinidis I . PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma. Clin Cancer Res. 2015; 22(2):470-8. PMC: 5296951. DOI: 10.1158/1078-0432.CCR-15-0715. View

17.

Rock K, Reits E, Neefjes J . Present Yourself! By MHC Class I and MHC Class II Molecules. Trends Immunol. 2016; 37(11):724-737. PMC: 5159193. DOI: 10.1016/j.it.2016.08.010. View

18.

van Essen T, van Pelt S, Bronkhorst I, Versluis M, Nemati F, Laurent C . Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes. PLoS One. 2016; 11(10):e0164292. PMC: 5072555. DOI: 10.1371/journal.pone.0164292. View

19.

Levy E, Bianchini M, von Euw E, Barrio M, Bravo A, Furman D . Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer. Int J Oncol. 2008; 32(3):633-41. View

20.

Boegel S, Lower M, Bukur T, Sorn P, Castle J, Sahin U . HLA and proteasome expression body map. BMC Med Genomics. 2018; 11(1):36. PMC: 5872580. DOI: 10.1186/s12920-018-0354-x. View